Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-06-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC). This action expands the sponsor's NDA…
-
FDA approval · 2016-06-13FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for Klonopin (clonazepam) from H2-Pharma, LLC. The action updates labeling as part of the supple…
-
FDA approval · 2016-06-10FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original ANDA for paroxetine (paroxetine hydrochloride), establishing a generic version of the antidepr…
-
CLINICAL_TRIALS research · 2016-05-06Clinical Trial Update: Internet-delivered Transdiagnostic Intervention for Anxiety and Depression [NA]
This clinical trial update describes an internet-delivered transdiagnostic intervention for anxiety and depression, covering multiple disord…
-
FDA approval · 2016-04-07FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for XANAX XR (alprazolam) submitted by Viatris Specialty LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Venlafaxine PK Following Bariatric Surgery [Phase 4]
Phase 4 study evaluating how bariatric surgery affects the pharmacokinetics of venlafaxine has completed, assessing changes in drug exposure…
-
FDA approval · 2016-03-24FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application to Chartwell RX, LLC for diazepam oral solution (concentrate), authorizing a generic version of this…
-
FDA approval · 2016-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling the commercialization of a gene…
-
FDA approval · 2016-03-14FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application from Quallent Pharmaceuticals Health LLC to market fluoxetine hydrochloride as a generic product…
-
FDA approval · 2016-02-29FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2016-01-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Treatment of Social Phobia and Panic Disorder in Adults [Phase 3]
Phase 3 clinical trial update on treatments for social anxiety disorder and panic disorder in adults. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients [Phase 4]
Phase 4 clinical trial update evaluating quetiapine extended-release (Seroquel SR) for SSRI-resistant panic disorder. Results have been post…
-
FDA approval · 2016-01-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a supplemental application for venlafaxine hydrochloride submitted by Zydus Pharmaceuticals USA Inc., resulting in regulatory a…
-
FDA approval · 2016-01-12FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine from Alembic Pharmaceuticals Limited.
-
FDA label_change · 2016-01-10FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc. to update the product labeling.
-
FDA approval · 2015-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Lupin Pharmaceuticals, Inc.), a generic product under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels [Phase 1]
A Phase 1 clinical trial evaluated whether gastric bypass surgery affects blood levels of the antidepressant venlafaxine ER.
-
CLINICAL_TRIALS research · 2015-12-16Clinical Trial Update: Disruption of Memory Reconsolidating as a Treatment for Panic Disorder [Phase 2]
Phase 2 clinical trial update investigating disruption of memory reconsolidation as a treatment for Panic Disorder. The sponsor is VU Univer…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Internet-based Self-help Treatment for Panic Disorder: Two Ways of Complementary Psychological Support [NA]
This entry reports a completed clinical trial from Universitat Autonoma de Barcelona evaluating two forms of complementary psychological sup…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Cortisol Evaluation in Abuse Survivors
A University of Bristol trial evaluating cortisol levels in survivors of abuse with depression and related anxiety disorders has completed.
-
FDA approval · 2015-11-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety [NA]
A terminated clinical trial evaluated ramelteon for sleep initiation insomnia in individuals with panic disorder who were taking escitalopra…
-
FDA approval · 2015-07-31FDA Approved: ALPRAZOLAM — Original Application (Aurobindo Pharma Limited)
The FDA approves Aurobindo Pharma Limited's generic alprazolam through an original ANDA submission, authorizing market entry of the generic …
-
CLINICAL_TRIALS research · 2015-06-24Clinical Trial Update: The Assessment and Treatment of Balance Impairment Using Virtual Reality (VR) in Panic Disorder Patients [NA]
This entry reports an ongoing clinical trial assessing virtual reality–based treatment for balance impairment in patients with panic disorde…